castgallon1
About
Heterologous prime-boost vaccination targeting MAGE-type antigens encourages tumour T-cell infiltration and also boosts checkpoint blockage therapy.
Heterologous prime-boost vaccination targeting MAGE-type antigens encourages tumour T-cell infiltration and also boosts checkpoint blockage therapy.